Angiotensin-converting enzyme 2: a new target for neurogenic hypertension
Robert Speth
Part of the Pharmacy and Pharmaceutical Sciences Commons
Works by Yumei Feng in Pharmacy and Pharmaceutical Sciences
2023
Brain-selective overexpression of human Angiotensin-converting enzyme type 2 attenuates neurogenic hypertension
Robert Speth
Intracerebroventricular infusion of the (Pro)renin receptor antagonist PRO20 attenuates deoxycorticosterone acetate-salt-induced hypertension.
Robert Speth